Requirement applications for deliberate release of gmo’s application for COVID-19 clinical trials COVID-19 is temporarily suspended On July 17 2020 the European Commission published a regulation that a day later, on 2020, July 18 took effect .
From 13 March 2020, submission of research dossiers for gene therapy and medicinal products containing GMOs takes place directly to the relevant authority From 13 March 2020, research dossiers in the field of gene therapy and medicinal products containing GMOs must be submitted directly to the relevant authority (CCMO as review committee, Ministry of He
Amendment to the 'Wet Milieubeheer' and the GMO Decree (cancellation of 6-week waiting period) As of July 1, 2019, after receiving a permit of the ministry of Infrastructure and Water Management, you no longer have to wait 6 weeks before you can start the activities.